Study participants were given the compound—known as intravenous Ig, or IVIg—for three years. During this period, they showed no signs of further cognitive decline or memory loss. Although the study was small, it provides hope that the devastating disease can be stopped or slowed in humans.
Watch Streaming Broadcast Live:
LRN.fm
Live Chat
Telegram
Share this page with your friends
on your favorite social network:
Loading...